Related Experiment Video
Updated: Mar 30, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective
Seung-Ju Cho1, So-Yeon Kim1, Ho-Chang Jeong1
1Department of Life Sciences, College of Natural Sciences, Sogang University, Seoul 121-742, Korea.
Abstract:
Stem-toxic small molecules have been developed to induce selective cell death of pluripotent stem cells (PSCs) to lower the risk of teratoma formation. However, despite their high efficacies, chemical-based approaches may carry unexpected toxicities on specific differentiated cell types. Herein, we took advantage of KillerRed (KR) as a suicide gene, to selectively induce phototoxicity using visible light via the production of reactive oxygen species. PSCs in an undifferentiated state that exclusively expressed KR (KR-PSCs) were eliminated by a single exposure to visible light. This highly selective cell death in KR-PSCs was exploited to successfully inhibit teratoma formation. In particular, endothelial cells from KR-mPSCs remained fully functional in vitro and sufficient to repair ischemic injury in vivo regardless of light exposure, suggesting that a genetic approach in which KR is expressed in a tightly controlled manner would be a viable strategy to inhibit teratoma formation for future safe PSC-based therapies.
Insights
Pluripotent stem cells (PSCs) expressing the KillerRed (KR) suicide gene can be selectively eliminated by light, preventing teratoma formation. This genetic approach offers a safer alternative to chemical methods for future stem cell therapies.
Area of Science:
- Regenerative Medicine
- Molecular Biology
- Biotechnology
Background:
- Pluripotent stem cells (PSCs) hold great therapeutic potential but pose a risk of teratoma formation.
- Current chemical methods to eliminate undifferentiated PSCs may cause off-target toxicities.
- Novel strategies are needed to ensure the safety of PSC-based therapies.
Purpose of the Study:
- To develop a light-inducible suicide gene system for selective PSC ablation.
- To evaluate the efficacy of this system in preventing teratoma formation.
- To assess the functional integrity of differentiated cells derived from modified PSCs.
Main Methods:
- Genetically engineered PSCs to express the KillerRed (KR) phototoxicity gene.
- Induced selective cell death of KR-expressing PSCs using visible light.
- Assessed teratoma formation inhibition in vivo.
- Evaluated the functionality of differentiated endothelial cells in vitro and in vivo.
Main Results:
- Visible light exposure efficiently eliminated KR-expressing PSCs (KR-PSCs).
- Teratoma formation was successfully inhibited using this phototoxic approach.
- Endothelial cells derived from KR-modified PSCs remained functional and capable of repairing ischemic injury.
- Light exposure did not compromise the function of differentiated endothelial cells.
Conclusions:
- The KR suicide gene system provides a highly selective method for ablating undifferentiated PSCs.
- This phototoxic genetic strategy effectively prevents teratoma formation.
- Controlled KR expression in PSCs is a viable and safe approach for future stem cell therapies, preserving the function of differentiated progeny.
More Related Videos
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020
05:18Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
Published on: March 14, 2016
Related Concept Videos
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells
Stem Cell Culture
EPS and iPS Cells in Disease Research
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...